Insider Selling: Stryker Director Sells 21,000 Shares of Stock (SYK)
Stryker (NYSE:SYK) Director Ronda E. Stryker unloaded 21,000 shares of the stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $83.23, for a total transaction of $1,747,830.00. Following the completion of the sale, the director now directly owns 174,605 shares of the company’s stock, valued at approximately $14,532,374. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
Shares of Stryker (NYSE:SYK) traded up 0.47% during mid-day trading on Wednesday, hitting $83.51. The stock had a trading volume of 999,848 shares. Stryker has a 1-year low of $66.52 and a 1-year high of $86.93. The stock’s 50-day moving average is $81.25 and its 200-day moving average is $81.63. The company has a market cap of $31.615 billion and a P/E ratio of 46.44.
Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, July 17th. The company reported $1.08 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $1.08. The company had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the prior year, the company posted $1.00 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. On average, analysts predict that Stryker will post $4.77 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, October 31st. Investors of record on Tuesday, September 30th will be paid a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a dividend yield of 1.47%. The ex-dividend date is Friday, September 26th.
A number of research firms have recently commented on SYK. Analysts at Needham & Company LLC upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Tuesday, August 12th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Stryker in a research note on Monday, July 21st. They now have a $86.00 price target on the stock. Finally, analysts at Citigroup Inc. reiterated a “neutral” rating on shares of Stryker in a research note on Monday, July 21st. They now have a $90.00 price target on the stock, up previously from $85.00. Eight investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Stryker presently has a consensus rating of “Buy” and a consensus price target of $86.18.
Stryker Corporation (NYSE:SYK) is a medical technology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.